Fecal Immunochemical Test (FIT) and Helicobacter pylori Stool Antigen Co-Testing for Gastric Cancer
Gastric cancer is a leading cause of cancer death globally. Chronic H pylori infection is the primary cause of gastric cancer, responsible for at least 80% of the new cases. Constanza Camargo, PhD, of the National Cancer Institute joins JAMA Associate Editor John M. Inadomi, MD, to discuss co-testing with FIT and H pylori stool antigen to help prevent gastric cancer. Related Content:
- Fecal Immunochemical Test and Helicobacter pylori Stool Antigen Co-Testing
- Screening for Helicobacter pylori to Prevent Gastric Cancer
Informations
- Émission
- Chaîne
- FréquenceChaque semaine
- Publiée30 septembre 2024 à 15:00 UTC
- Durée12 min
- ClassificationTous publics